Solid Tumor Advisors
Jordan D. Berlin, M.D.
Co-Leader, Gastrointestinal Cancer Research Program, Professor of Medicine (Hematology/Oncology), Director, Phase I Program, Medical Oncologist, Vanderbilt-Ingram Cancer Center
J. Randolph Hecht, M.D.
Director, Gastrointestinal Cancer Program, Professor of Clinical Medicine, David Geffen School of Medicine at UCLA
Heloisa P. Soares, M.D., Ph.D.
Section leader, HPB cancers and NETs clinical program, University of New Mexico Comprehensive Cancer Center
Josep Tabernero M.D., Ph.D.
Head, Medical Oncology Dept, the Vall d´Hebron University Hospital. Director, Vall d´Hebron Institute of Oncology (VHIO), Barcelona Area, Spain
Eric Van Cutsem, M.D., Ph.D.
Medical Doctor and Professor of Medicine (Digestive Oncology) at University Hospital Gasthuisberg/Leuven, Belgium
Acute Myeloid Leukemia Advisors
Jorge Cortes, M.D.
Acute Myeloid Leukemia Advisor
Director of The Georgia Cancer Center at Augusta University. He is designated as a Georgia Research Alliance Eminent Scholar in Cancer in the Medical College of Georgia.
Bayard L. Powell, M.D.
Section Chief, Hematology & Oncology, Associate Director for Clinical Research, Comprehensive Cancer Center, Professor, Hematology & Oncology, Wake Forest Baptist Medical Center
Mikkael Sekeres, M.D.
Director, Leukemia Program, Vice-chair for Clinical Research, Cleveland Clinic’s Taussig Cancer Institute
Richard M. Stone, M.D.
Professor of Medicine, Harvard Medical School; Associate Physician, Medicine, Brigham And Women’s Hospital; Director, Adult Leukemia Program, Dana-Farber Cancer Institute
Craig H. Moskowitz, M.D.
Physician in Chief, Oncology Service Line, Sylvester Comprehensive Cancer Center Professor, Department of Medicine
Ariela Noy, M.D.
Attending Physician and Member: Hematology Divistion/Lymphoma Service; Memorial Sloan-Kettering Cancer Center; Chair of the Lymphoma Working Group for the AIDS Malignancy Consortium
Steven I. Park, M.D.
Division Chief, Hematology and Oncology, Levine Cancer Institute, CHS-Northeast; Director of Investigational Therapeutics in Hematologic Malignancies, Levine Cancer Institute/Carolinas HealthCare System; Associate Professor of Medicine, University of North Carolina, Chapel Hill